About the Center

About the Center
 
The King Hussein Cancer Center (KHCC) is one of the best comprehensive cancer centers in the Middle East which treats both adult and pediatric patients. KHCC is named after our late beloved King Hussein who fought cancer in the same manner as he lived his life; with great faith, courage and dignity.
 
KHCC treats over 3500 new cancer patients each year, from Jordan and the region. It is equipped with state-of-the-art medical equipment and services, including 8 operating rooms and 170 beds. It houses 18 intensive care units, including 6 ICU specialized for pediatric care. Highly-qualified oncologists and healthcare professionals (over 200 oncologists and consultants) and 617 nurses, trained specifically in oncology nursing, work tirelessly to ensure that patients receive the latest in comprehensive cancer care.
 
KHCC delivers comprehensive cancer care by treating patients as a “whole”, focusing on their physical, emotional and social well-being. In that regard, KHCC has established programs which focus on all stages of comprehensive cancer care: from prevention and early detection, through diagnosis and treatment, to palliative care. KHCC offers many services to ensure that patients are supported throughout their difficult treatment, including: survivor groups, a physical rehabilitation program, a nutrition clinic, a psycho-oncology clinic, and a pediatric pain management clinic among many others.
 
KHCC treats all cancers and performs approximately 100 bone marrow transplants (BMT) a year. The KHCC BMT program is one of the largest and most successful programs in the Middle East, achieving cure rates compatible with international standards. It oversees both matched allogeneic and autologous transplants. The KHCC BMT program also performs transplants utilizing cord blood, making it the only program in Jordan, and one of only two in the region, which offers such highly-specialized transplants for both adult and pediatric patients. Non-cancer cases are also treated through the KHCC BMT program including thalassemia, aplastic anemia and other metabolic diseases.